These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38149816)

  • 1. Up-regulation of TNF-alpha/NFkB/SIRT1 axis drives aggressiveness and cancer stem cells accumulation in chemoresistant oral squamous cell carcinoma.
    de Castro LR; de Oliveira LD; Milan TM; Eskenazi APE; Bighetti-Trevisan RL; de Almeida OGG; Amorim MLM; Squarize CH; Castilho RM; de Almeida LO
    J Cell Physiol; 2024 Feb; 239(2):e31164. PubMed ID: 38149816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological inhibition of HDAC6 overcomes cisplatin chemoresistance by targeting cancer stem cells in oral squamous cell carcinoma.
    Tavares MO; Milan TM; Bighetti-Trevisan RL; Leopoldino AM; de Almeida LO
    J Oral Pathol Med; 2022 Jul; 51(6):529-537. PubMed ID: 35678235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epithelial-mesenchymal transition and cancer stem cells: A route to acquired cisplatin resistance through epigenetics in HNSCC.
    Lima de Oliveira J; Moré Milan T; Longo Bighetti-Trevisan R; Fernandes RR; Machado Leopoldino A; Oliveira de Almeida L
    Oral Dis; 2023 Jul; 29(5):1991-2005. PubMed ID: 35403781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic modifications control loss of adhesion and aggressiveness of cancer stem cells derived from head and neck squamous cell carcinoma with intrinsic resistance to cisplatin.
    Milan TM; Eskenazi APE; Bighetti-Trevisan RL; de Almeida LO
    Arch Oral Biol; 2022 Sep; 141():105468. PubMed ID: 35679799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
    Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
    J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CMTM6 drives cisplatin resistance by regulating Wnt signaling through the ENO-1/AKT/GSK3β axis.
    Mohapatra P; Shriwas O; Mohanty S; Ghosh A; Smita S; Kaushik SR; Arya R; Rath R; Das Majumdar SK; Muduly DK; Raghav SK; Nanda RK; Dash R
    JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33434185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DDX3 modulates cisplatin resistance in OSCC through ALKBH5-mediated m
    Shriwas O; Priyadarshini M; Samal SK; Rath R; Panda S; Das Majumdar SK; Muduly DK; Botlagunta M; Dash R
    Apoptosis; 2020 Apr; 25(3-4):233-246. PubMed ID: 31974865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
    Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
    Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analyses of Sirt1-mediated cisplatin resistance in OSCC cell line.
    Xiong P; Li YX; Tang YT; Chen HG
    Protein J; 2011 Oct; 30(7):499-508. PubMed ID: 21947960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay between EZH2/β-catenin in stemness of cisplatin-resistant HNSCC and their role as therapeutic targets.
    Milan TM; Eskenazi APE; Oliveira LD; Silva GD; Bighetti-Trevisan RL; Freitas GP; Almeida LO
    Cell Signal; 2023 Sep; 109():110773. PubMed ID: 37331417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL3/14 and IL-17 signaling contribute to CEBPA-DT enhanced oral cancer cisplatin resistance.
    Qiao X; Zhu L; Song R; Shang C; Guo Y
    Oral Dis; 2023 Apr; 29(3):942-956. PubMed ID: 34807506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supramolecular nanodrug targeting CDK4/6 overcomes BAG1 mediated cisplatin resistance in oral squamous cell carcinoma.
    Zhao B; Qin X; Fu R; Yang M; Hu X; Zhao S; Cui Y; Guo Q; Zhou W
    J Control Release; 2024 Apr; 368():623-636. PubMed ID: 38479445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma.
    Liu T; Chen G; Sun D; Lei M; Li Y; Zhou C; Li X; Xue W; Wang H; Liu C; Xu J
    Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):808-816. PubMed ID: 28910982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
    Kulsum S; Sudheendra HV; Pandian R; Ravindra DR; Siddappa G; R N; Chevour P; Ramachandran B; Sagar M; Jayaprakash A; Mehta A; Kekatpure V; Hedne N; Kuriakose MA; Suresh A
    Mol Carcinog; 2017 Feb; 56(2):694-711. PubMed ID: 27380877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.
    Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY
    J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pERK-mediated IL8 secretion can enhance the migration, invasion, and cisplatin resistance of CD10-positive oral cancer cells.
    Pu Y; Li Q; Wang Y; Xu L; Qiao Q; Guo Y; Guo C
    BMC Cancer; 2021 Dec; 21(1):1283. PubMed ID: 34847866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pluripotency transcription factor Nanog and its association with overall oral squamous cell carcinoma progression, cisplatin-resistance, invasion and stemness acquisition.
    Kashyap T; Nath N; Mishra P; Jha A; Nagini S; Mishra R
    Head Neck; 2020 Nov; 42(11):3282-3294. PubMed ID: 32710593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical β-catenin pathway.
    Zhang X; Sun K; Gan R; Yan Y; Zhang C; Zheng D; Lu Y
    BMC Cancer; 2024 May; 24(1):564. PubMed ID: 38711026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STAT3- and GSK3β-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma.
    Maji S; Shriwas O; Samal SK; Priyadarshini M; Rath R; Panda S; Das Majumdar SK; Muduly DK; Dash R
    Carcinogenesis; 2019 Mar; 40(1):173-183. PubMed ID: 30395230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.